Spots Global Cancer Trial Database for Study of BMS-986393 a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study of BMS-986393 a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
Official Title: A Phase 2, Open-Label, Multicenter Study of BMS-986393, a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma (QUINTESSENTIAL)
Study ID: NCT06297226
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to evaluate the effectiveness and safety of BMS-986393 in participants with relapsed or refractory multiple myeloma.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Local Institution - 0001, Birmingham, Alabama, United States
Local Institution - 0025, Gilbert, Arizona, United States
Local Institution - 0037, Little Rock, Arkansas, United States
UCLA Hematology/Oncology - Westwood (Building 200 Suite 214), Los Angeles, California, United States
Local Institution - 0018, San Francisco, California, United States
Colorado Blood Cancer Institute, Denver, Colorado, United States
Local Institution - 0045, Miami, Florida, United States
Local Institution - 0029, Tampa, Florida, United States
Local Institution - 0009, Atlanta, Georgia, United States
Local Institution - 0004, Atlanta, Georgia, United States
Local Institution - 0005, Chicago, Illinois, United States
Local Institution - 0056, Chicago, Illinois, United States
University of Iowa, Iowa City, Iowa, United States
Local Institution - 0016, Westwood, Kansas, United States
Local Institution - 0026, Saint Matthews, Kentucky, United States
Local Institution - 0039, Boston, Massachusetts, United States
Local Institution - 0036, Boston, Massachusetts, United States
Local Institution - 0033, Rochester, Minnesota, United States
Washington University School of Medicine, Saint Louis, Missouri, United States
Local Institution - 0034, New Brunswick, New Jersey, United States
Local Institution - 0046, Buffalo, New York, United States
Local Institution - 0002, New York, New York, United States
Local Institution - 0003, New York, New York, United States
Local Institution - 0031, Chapel Hill, North Carolina, United States
Local Institution - 0054, Cincinnati, Ohio, United States
Local Institution - 0032, Columbus, Ohio, United States
Local Institution - 0038, Portland, Oregon, United States
Local Institution - 0043, Nashville, Tennessee, United States
Local Institution - 0035, Dallas, Texas, United States
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Local Institution - 0055, San Antonio, Texas, United States
Local Institution - 0050, Salt Lake City, Utah, United States
Local Institution - 0011, Seattle, Washington, United States
University Hospital and UW Health Clinics, Madison, Wisconsin, United States
Local Institution - 0020, Calgary, Alberta, Canada
Local Institution - 0021, Montréal, Quebec, Canada
Contact Details
Name: Bristol-Myers Squibb
Affiliation: Bristol-Myers Squibb
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
